This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by de Silva Rudland, S. Articles by Rudland, P. Search for Related Content PubMed PubMed Citation Articles by de Silva Rudland, S. Articles by Rudland, P.

Association of S100A4 and Osteopontin with Specific Prognostic Factors and Survival of Patients with Minimally Invasive Breast Cancer

Authors' Affiliations: ¹ Cancer and Polio Research Fund Laboratories, School of Biological Sciences; ² Department of Surgery, Royal Liverpool University Hospital; Departments of ³ Surgery and ⁴ Public Health; and ⁵ Cancer Tissue Bank Research Centre, University of Liverpool, Liverpool, United Kingdom

Requests for reprints: Philip S. Rudland, School of Biological Sciences, Biosciences Building, University of Liverpool, Liverpool, L69 3BX, United Kingdom. Phone: 44-151-795-4474; Fax: 44-151-795-4406; E-mail: sdsrudland{at}yahoo.com.

Purpose: S100A4 and the estrogen-inducible osteopontin are alone capable of inducing angiogenesis and metastasis in rodent models for breast cancer. The present study assesses the relationship of S100A4 and osteopontin with vessel density and estrogen receptor (ER) in primary tumors and with survival of patients to ascertain their involvement in metastatic breast cancer.

Experimental Design: Primary tumors from 312 patients treated for minimally invasive human breast cancer were immunocytochemically stained and then assessed for the significance of their association with each other using Fisher's exact test or with patient survival over 18 years of follow-up using Kaplan-Meier plots and Wilcoxon-Gehan statistics.

Results: Antibodies to S100A4 significantly stained endothelial cells of vessels adjacent to S100A4-staining groups of carcinoma cells, and antibodies to osteopontin significantly stained groups of carcinoma cells staining for ER (P < 0.0001). There was a significant association of tumors staining for S100A4 with those with high vessel density (P = 0.021) and of tumors staining for osteopontin with those staining for ER (P = 0.034). The association of staining for S100A4, osteopontin, or vessel density with patient death was significant (P < 0.0001, P = 0.005, and P = 0.014, respectively). The difference in cumulative proportion surviving between S100A4-positive patients with higher or lower vessel density increased up to about 12 years, but thereafter decreased to virtually zero after 18 years of follow-up. Patients with both S100A4-positive and osteopontin-positive primary tumors showed a statistically significant reduction in survival time over those with either one alone (P < 0.019), although in multivariate regression analysis, only staining for S100A4 was significant (P < 0.001).

Conclusions: It is suggested that in human breast cancer, S100A4 exerts some of its effects through angiogenesis, and that osteopontin is dependent on ER for its expression.

This article has been cited by other articles:

				F. Fang, A. J. Flegler, P. Du, S. Lin, and C. V. Clevenger Expression of Cyclophilin B is Associated with Malignant Progression and Regulation of Genes Implicated in the Pathogenesis of Breast Cancer Am. J. Pathol., January 1, 2009; 174(1): 297 - 308. [Abstract] [Full Text] [PDF]

				C. K. Mason, S. McFarlane, P. G. Johnston, P. Crowe, P. J. Erwin, M. M. Domostoj, F. C. Campbell, S. Manaviazar, K. J. Hale, and M. El-Tanani Agelastatin A: a novel inhibitor of osteopontin-mediated adhesion, invasion, and colony formation Mol. Cancer Ther., March 1, 2008; 7(3): 548 - 558. [Abstract] [Full Text] [PDF]

				B.-D. Grigoriu, A. Scherpereel, P. Devos, B. Chahine, M. Letourneux, P. Lebailly, M. Gregoire, H. Porte, M.-C. Copin, and P. Lassalle Utility of Osteopontin and Serum Mesothelin in Malignant Pleural Mesothelioma Diagnosis and Prognosis Assessment Clin. Cancer Res., May 15, 2007; 13(10): 2928 - 2935. [Abstract] [Full Text] [PDF]

				M. Saleem, M.-H. Kweon, J. J. Johnson, V. M. Adhami, I. Elcheva, N. Khan, B. Bin Hafeez, K. M. R. Bhat, S. Sarfaraz, S. Reagan-Shaw, et al. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9 PNAS, October 3, 2006; 103(40): 14825 - 14830. [Abstract] [Full Text] [PDF]